Veracyte Inc

Common Name

Veracyte

Country

United States

Sector

Healthcare

Industry

Diagnostics & Research

Employees

824

Ticker

VCYT

Exchange

NASDAQ/NMS

Website

www.veracyte.com

Description

Veracyte Inc. is a genomic diagnostics company specializing in advanced molecular diagnostic tests that address critical healthcare needs. The primary function of Veracyte is to improve patient outcom... Show more

Financial Statements of Veracyte

Below are the financial statements of Veracyte, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	239.09^a	216.45^a
Short-term investments	50.35^a	0^a
Accounts receivable	46.53^a	40.38^a
Supplies and inventory	21.75^a	16.13^a
Prepaid expenses and other current assets	14.55^a	12.66^a
Total current assets	372.27^a	285.62^a
Assets	—	—
Property, plant and equipment, net	22.95^a	20.58^a
Right-of-use assets, operating leases	48.19^a	10.28^a
Intangible assets, net	102.3^a	88.59^a
Goodwill	745.8^a	702.98^a
Restricted cash	1.54^a	0.88^a
Other assets	6.98^a	5.97^a
Total assets	1,300.04^a	1,114.91^a
Current liabilities	—	—
Accounts payable	8.63^a	12.94^a
Accrued liabilities	43.83^a	38.43^a
Current portion of deferred revenue	1.67^a	2.01^a
Current portion of acquisition-related contingent consideration	16.98^a	2.66^a
Current portion of operating lease liabilities	7.5^a	5.11^a
Current portion of other liabilities	0.02^a	0.1^a
Total current liabilities	78.63^a	61.24^a
Liabilities and stockholders' equity	—	—
Deferred tax liability	1.23^a	0.73^a
Acquisition-related contingent consideration, net of current portion	0.56^a	0.52^a
Operating lease liabilities, net of current portion	43.24^a	7.53^a
Other liabilities	0.41^a	0.79^a
Total liabilities	124.07^a	70.8^a
Stockholders' equity	—	—
Preferred stock	0^a	0^a
Common stock	0.08^a	0.07^a
Additional paid-in capital	1,655.96^a	1,536.17^a
Accumulated deficit	-443.98^a	-468.12^a
Accumulated other comprehensive loss	-36.09^a	-24.02^a
Total stockholders' equity	1,175.97^a	1,044.1^a
Total liabilities and stockholders' equity	1,300.04^a	1,114.91^a

Verified Sources Behind Veracyte’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Veracyte’s data sources below and access millions more through our Disclosure Search.

a. Veracyte's 10-K 2024

Trace every data point back to Veracyte’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Veracyte Inc

Financial Statements of Veracyte

Verified Sources Behind Veracyte’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Charles River Laboratories International Inc

Revvity Inc

Quest Diagnostics Inc

Guardant Health Inc

Danaher Corp

Laboratory Corporation of America Holdings